• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为不良反应数据的产生者和使用者的执业医师。

The practicing physician as generator and user of adverse reaction data.

作者信息

Venulet J

出版信息

Int J Clin Pharmacol Ther Toxicol. 1986 Jul;24(7):385-9.

PMID:3733289
Abstract

Information about adverse drug reactions (ADR) helps the practicing physician to optimize his pharmacotherapy, however, he also generates most of the original observations and thus he is largely responsible for the quality of ADR data. As direct communication from physician to physician is limited other means had to be developed such as scientific papers, communication from health authorities and from the pharmaceutical industry. The paper discusses the characteristics of the elements involved in the process of generating assessing and disseminating ADR data and of their interplay.

摘要

关于药物不良反应(ADR)的信息有助于执业医师优化其药物治疗方案,然而,大多数原始观察结果也是由医师做出的,因此,ADR数据的质量很大程度上由医师负责。由于医师之间的直接交流有限,因此必须开发其他方式,如科学论文、卫生当局和制药行业的交流。本文讨论了ADR数据生成、评估和传播过程中各要素的特点及其相互作用。

相似文献

1
The practicing physician as generator and user of adverse reaction data.作为不良反应数据的产生者和使用者的执业医师。
Int J Clin Pharmacol Ther Toxicol. 1986 Jul;24(7):385-9.
2
Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.由药物信息服务机构协调开展的项目,旨在改善医院的药品不良反应报告情况。
Am J Hosp Pharm. 1986 Sep;43(9):2202-5.
3
Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.简短通讯:一家三级护理教学医院药物信息中心收到的药物不良反应相关咨询模式
Pak J Pharm Sci. 2007 Oct;20(4):333-9.
4
[Communication and transparency concerning risk-benefit analysis in public health: the example of medication].公共卫生中风险效益分析的沟通与透明度:以药物为例
Therapie. 2001 Jul-Aug;56(4):335-9.
5
Food and Drug Administration monitoring of adverse drug reactions.美国食品药品监督管理局对药品不良反应的监测。
Am J Hosp Pharm. 1986 Nov;43(11):2764-70.
6
[Interactions and adverse drug reactions: how to obtain information].[相互作用与药物不良反应:如何获取信息]
Praxis (Bern 1994). 1999 Apr 15;88(16):713-8.
7
[Organization and results of drug vigilance in France].[法国药物警戒的组织与成果]
Rev Epidemiol Sante Publique. 1994;42(5):416-23.
8
Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).用药差错:一项比较PHICO的结案索赔数据与PHICO事件报告趋势系统(PERTS)的分析。
J Clin Pharmacol. 2003 Jul;43(7):754-9.
9
[Ensuring safe medication in the physician's office].[确保医生办公室的用药安全]
MMW Fortschr Med. 2006 May 11;148(19):44-5.
10
[Patient education responsibility, specialty and administration information from the viewpoint of the pharmaceutical industry].[从制药行业视角看患者教育责任、专业领域及管理信息]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):649-53.

引用本文的文献

1
Harmonising adverse drug reaction terminology: the role of the Council for International Organizations of Medical Sciences.统一药品不良反应术语:国际医学科学组织理事会的作用
Drug Saf. 1998 Sep;19(3):165-72. doi: 10.2165/00002018-199819030-00001.
2
Benefit/risk ratio of new drugs: for whom? Discussion paper.新药的效益/风险比:针对谁?讨论文件。
J R Soc Med. 1988 Mar;81(3):155-7. doi: 10.1177/014107688808100312.